The Ultra Processed Food Test Case the Industry Hasn't Stress-Tested

The label reads fifty percent more protein than regular milk. Half the sugar. No lactose. It tastes like milk. It pours like milk. It sits in the dairy case next to milk.

But it is not milk. Not in the way the category has defined milk for a century.

What is inside the package is the result of a process that takes conventional milk and separates it into its constituent parts, water, butterfat, protein, vitamins and minerals, lactose, and then reassembles those parts in proportions that do not occur in any cow on any farm anywhere on earth. More of the protein. More of the calcium. Less of the sugar. The lactose removed entirely.

The industry calls it ultra-filtration. And unlike most products that win on nutritional claims, this one actually delivers on the experience. It tastes rich, clean, familiar. There is no chalkiness from added protein powder. No thin watery compromise. No aftertaste reminding the consumer that they chose the healthy option. This is one of the rare cases in food science where the reformulation is genuinely better than the original for most people, and the repeat purchase rates reflect it.

Helmsman Group works with a limited number of manufacturers, cooperatives, and investors each quarter on UPF exposure, evaluating how specific products, processes, and capacity decisions hold up against the NOVA framework, the emerging federal definition, and the scenarios between them.

This work typically begins with a focused discussion and, where needed, extends into a detailed assessment used for internal strategy, capital planning, or board-level decisions.

If you’re actively building or investing in this space, it’s worth understanding where you stand.

The category has grown roughly seventy-one percent over four years to about $8.1 billion in dollar sales. Coca-Cola committed $650 million to a single new production facility for this technology. Michigan Milk Producers Association is building ultra-filtered capacity. Dairy cooperatives across the upper Midwest are converting fluid assets to UF lines. It is the fastest-growing segment in the dairy aisle by a wide margin.

So far this reads like a success story. And it is. But there is more to this story than the numbers on the shelf and the product on the line. That is what I want to show you.

Most people in the industry have never been walked through what is actually happening inside a UF facility. There is no reason they would have been. The equipment vendors describe it as membrane separation. The brand teams describe it as cold-filtration. The label reads like milk.

But what happens between the farm and the line is worth understanding. Not because it is dangerous. Because it is fascinating and because the gap between what this process actually is and what the rules assume it is, is about to become one of the most consequential mismatches in the food industry.

Conventional milk processing is relatively simple. Pasteurize to kill pathogens. Homogenize to distribute the fat evenly. Package. Ship cold. The product that leaves the plant is recognizably the same substance that came out of the cow, with the addition of heat treatment for safety.

Ultra-filtration is a fundamentally different approach. The milk passes through a series of membranes with pore sizes so fine they separate the liquid into its constituent parts based on the size of each component. Proteins and fat are too large to pass through. Water, lactose and some minerals pass through. What you end up with is not milk that has been cleaned up. It is milk that has been taken apart and put back together.

The industry built a brand around this. Fairlife called it "patented cold-filtration" and positioned it as innovation that enhances nature without additives. That is a fair description of the outcome. Fifty percent more protein without adding protein powder. Half the sugar without adding sweetener. Lactose-free without the enzymatic treatment that conventional lactose-free milk requires. The product is genuinely elegant from a formulation perspective.

But the concept has never been entirely settled in the consumer mind. When fairlife first launched, Euromonitor analysts noted that some shoppers were uneasy with the idea of pulling milk apart and reassembling it. One analyst called it "the Frankenstein of milk." That discomfort has been outrun by the product experience and the nutritional profile. But it has not disappeared. It sits quietly in the same cultural space where the conversation about ultra-processed foods is gaining volume every month. A product people love but feel vaguely uncertain about the process behind.

That uncertainty is about to find a regulatory vocabulary.

Here is something most people in the industry do not know and almost no one outside the industry has heard.

The foundational intellectual property that protected the ultra-filtered milk category has expired.

Mike McCloskey, John Dunker and Timothy Gomez filed an international patent application in 2003 describing a method of fractionating milk into its individual components and recombining them in different proportions. That patent family became the basis for fairlife's proprietary cold-filtration process and the cornerstone of a brand positioning built around a technology nobody else could legally replicate.

That foundational patent family is now in the public domain.

Newer patents around specific process refinements continue to be filed and granted. Fairlife received a patent as recently as October 2023 covering forward osmosis methods for dairy composition preparation. But the base technology, the core method of fractionating milk and recombining the parts, is open. Anyone with the capital and the process engineering expertise can build.

And they are building.

The Helmsman Group sits at the convergence of formulation, process engineering, aseptic validation, regulatory architecture and the litigation exposure that increasingly follows when any of those pieces are not handled correctly. That position is not incidental. It is why the phone rings. The list of people who can do this work at the level it needs to be done is short, and the industry knows it.

One of the leading indicators that crosses our desks is aseptic validation demand. When a manufacturer commissions a new aseptic line, whether it is Tetra Pak VTIS or any other system, the process cannot go live until someone validates that the thermal process achieves commercial sterility for the specific product being run through it. You cannot commission a new aseptic line without that validation. Which means the validation demand curve is a leading indicator of where the industry is actually investing, months ahead of the press release.

Right now the demand is extraordinary. New aseptic capacity is being built at a rate I have not experienced in three decades. Greenfield facilities with investment approaching half a billion dollars. Multiple lines. Multiple product formats. Recent engagements include a nine-figure LACF facility with the FDA in the room for pre-filing review and commercial sterility validation across a full aseptic line. That is one project. There are others. The public announcements, Coca-Cola's $650 million fairlife expansion in Webster New York, Michigan Milk Producers Association building ultra-filtered capacity, those are the visible part. What we are seeing from inside the work is the rest of the iceberg.

When someone asks us to validate an aseptic process or architect a regulatory position, the capital is already committed. The concrete is already poured. They are not exploring an option. They are bringing capacity online.

The CoBank data showing this category growing seventy-one percent over four years to $8.1 billion is telling you what happened. What we are telling you is what is about to happen. The capacity coming online in the next eighteen to thirty-six months will dwarf what is currently in production.

The patent wall fell and the capital followed.

And now the part of this story that makes everything else urgent.

Here is where it helps to step back and think about what ultra-filtration actually is at a process level. The industry uses the word "filtration" which sounds gentle and mechanical. But what is happening is fractionation. The same principle the energy industry uses when it takes crude oil or natural gas and breaks it into constituent parts to extract what is most valuable. Nobody in dairy wants to hear the comparison. But it is structurally accurate. You are fracking milk. Taking a whole food, breaking it into its constituent parts through an industrial process, and reassembling those parts into something the source material never was.

That is not an indictment. The nutritional outcome of milk fractionation is genuinely positive. More protein and less sugar is a better product for most consumers. But the process itself, fractionation and recombination, is exactly what the emerging regulatory frameworks are designed to scrutinize. And that is a conversation the industry has not had.

Four regulatory bodies are shaping the federal definition of ultra-processed food simultaneously, moving in rough coordination rather than isolation. FDA and USDA opened the joint definitional process with a formal Request for Information in July 2025 and closed the comment period that September. The agencies are now analyzing the comment record, and FDA's 2026 Human Foods Program priorities confirm that a proposed federal UPF definition is on track this year. HHS has made ultra-processed food the centerpiece of its chronic disease strategy, and Secretary Kennedy has called UPF the driver of the chronic disease epidemic. Kennedy has also encouraged state attorneys general to treat UPF marketing with the same legal posture they applied to tobacco. Fifteen state legislatures introduced UPF-related bills in 2025, and ingredient warning-label laws in Texas and West Virginia take effect in 2027 and 2028. The four efforts are not identical. They converge on a single question. What counts as ultra-processed.

The reference point the federal process is using is the NOVA classification system, which categorizes products by the extent and purpose of processing. NOVA Group 4, the ultra-processed tier, specifically targets processes that fractionate whole foods into parts and recombine them.

Ultra-filtered milk fractionates whole milk into parts and recombines them.

The classification frameworks as currently constructed cannot distinguish between fractionation that enhances nutritional value and fractionation that strips it away. A process that separates milk into its constituent parts and recombines them to deliver more protein and less sugar looks structurally identical, through the lens of NOVA, to a process that separates corn into its constituent parts and recombines them for entirely different purposes. The frameworks see the process. They do not see the intent. And that is the industry's problem to solve before someone else solves it in a way the industry does not like.

Seventy percent of packaged products could be classified as ultra-processed under current frameworks. If ultra-filtered milk gets swept into that classification because the definition is process-based rather than formulation-based, a multi-billion dollar category built on genuine nutritional improvement faces regulatory exposure, labeling exposure, marketing exposure and the litigation exposure that follows once the plaintiff's bar finds its theory. Classifications do not live in a vacuum. State AG actions follow. Private plaintiffs file. Retailers reassess dairy sets and private-label UF programs. Procurement specs get rewritten. Every executive committing nine-figure capital into this buildout is making that commitment into a regulatory environment that has not yet decided what their product is.

Job Ubbink at the University of Minnesota has articulated this distinction precisely. In most cases it is the formulation more than the processing that results in foods that are not recommended as part of a healthy diet. The term he proposes is "ultra formulated" rather than "ultra processed." That distinction matters. It is the difference between coherent policy and a framework that inadvertently stigmatizes some of the most nutritionally valuable innovations the dairy industry has produced.

For the executive building capacity or the processor investing in membrane systems right now, the opportunity is real and the window is open. But the regulatory landscape is shifting underneath them and the frameworks being written today will determine whether the products coming off those lines tomorrow are celebrated as nutritional innovation or caught in a classification that was never designed with them in mind.

This is one of those rare moments where the technology, the demand signal, the capital and the regulatory vacuum all exist at the same time. That combination does not last. It never does. The companies that see it clearly and move decisively will define this category for the next decade.

Somewhere right now a facility is being built. The membrane systems are on order. The aseptic lines are being spec'd. Somebody will call us to validate the process, architect the regulatory position, structure the documentation that has to survive the next decade of scrutiny. We will ask them how they plan to classify the product under the framework being written. And I already know what most of them will say.

They will say they have not thought about it yet.

That is the gap. Between the speed of the capital and the speed of the conversation. Between what the industry is building and what the regulators are defining. Between the product on the line and the framework that will determine whether it thrives or gets caught in a classification it was never designed to fit.

The concrete is curing. The definitions are not.

Next in this series:
The Sixth Force. How AI infrastructure is compressing the timeline for every trend in this industry and why the gap between adopters and laggards is about to become unbridgeable.

Mark Haas is the founder and CEO of The Helmsman Group, a Portland-based food science, process engineering, and regulatory consulting firm, and co-founder of RegulateCPG, an AI-powered compliance infrastructure platform for the food and beverage industry. With 35 years of experience and more than 500 brands formulated, Mark is one of roughly 100 Process Authorities recognized by AFDO, with aseptic processing specialization. He partners with NVIDIA, Microsoft, and AWS to build AI infrastructure for food and beverage compliance.

For more insights on the forces reshaping this industry, visit regulatecpg.com or connect with Mark on LinkedIn. Mark works directly with a small number of CEOs, boards and investment committees each quarter on regulatory architecture, classification strategy and capital deployment decisions in the UF and aseptic categories. Engagements begin with a confidential conversation.

Legal Disclaimer: This article discusses regulatory strategy and industry dynamics but does not constitute legal advice. Companies should consult qualified food law attorneys and regulatory counsel for guidance on specific classification and compliance questions applicable to their products.

If you are building or investing in ultra-filtered or aseptic dairy, the question is not whether the category will grow.

It is how your specific product, process, and capacity decisions will be interpreted under the definitions being written now.

This is where most teams do not have clarity.

A small number of leaders each quarter work directly with us to evaluate how their systems align with UPF classification, regulatory direction, and the scenarios between them.

These conversations are specific, confidential, and grounded in what is actually being built.

They begin with a simple discussion.